首页 › 弥漫性硬皮病 › 纽约州 › New York City
New York City NY 弥漫性硬皮病临床试验
8项针对 弥漫性硬皮病的研究正在 New York City及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
招募中2 期
- Hospital for Special Surgery, New York
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
招募中1 期
- Icahn School of Medicine at Mount Sinai, New York
A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
招募中3 期
- GSK Investigational Site, New York
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
招募中2/3 期
- GSK Investigational Site, New York
- GSK Investigational Site, New York
Platform Clinical Study for Conquering Scleroderma
招募中2 期
- Hospital for Special Surgery, New York
- Columbia University Medical Center, New York
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
招募中2/3 期
- Columbia University Irving Medical Center, New York
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
招募中1/2 期
- Nkarta Investigational Site, New York
Scleroderma Registry & Repository at the Hospital for Special Surgery
招募中观察性研究欢迎健康志愿者
- Hospital for Special Surgery, New York
其他城市的 弥漫性硬皮病试验
- Ann Arbor, MI7 项研究
- Chicago, IL7 项研究
- Durham, NC6 项研究
- Los Angeles, CA6 项研究
- Houston, TX5 项研究
- Boston, MA5 项研究
- Baltimore, MD5 项研究
- New Orleans, LA4 项研究
- Pittsburgh, PA4 项研究
- Kansas City, KS4 项研究
- Philadelphia, PA4 项研究
- Dallas, TX3 项研究
New York City的其他研究
- 乳腺癌134 项研究
- 非小细胞肺癌120 项研究
- 癌症（所有类型）110 项研究
- 前列腺癌103 项研究
- 转移性癌症93 项研究
- 结直肠癌77 项研究
- 卵巢癌69 项研究
- 肺癌60 项研究
- 胰腺癌60 项研究
- 多发性骨髓瘤60 项研究
- 子宫内膜癌52 项研究
- 心力衰竭51 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。